Diageo plc (DGE.L) — Company Research
Last Updated: 8 June 2026
Diageo is the world's largest premium spirits company, owner of Johnnie Walker, Guinness, Smirnoff, Tanqueray, Don Julio and Crown Royal, with 13 billion-dollar brands and sales in nearly 180 countries. The fiscal 2025 year (ended 30 June 2025) was, in the company's own words, "challenging": reported net sales were broadly flat at $20.2 billion, a large exceptional impairment cut reported operating profit by almost 28%, and net debt sat at $21.9 billion. Since then the shares have continued to de-rate, a half-year dividend cut landed in February 2026, and new Chief Executive Sir Dave Lewis — the former Tesco boss who took the helm on 1 January 2026 — has begun dismantling the premiumisation strategy in favour of affordability and ready-to-drink growth. This report sets out what the published filings actually say.
1. Company Snapshot
| Field | Value |
|---|---|
| Company | Diageo plc |
| Ticker / Listing | DGE.L (London Stock Exchange); ADR DEO (NYSE) |
| Sector | Consumer & Retail — alcoholic beverages (premium spirits & beer) |
| CEO / Leadership | Sir Dave Lewis (Chief Executive Officer from 1 January 2026; former Tesco CEO). Nik Jhangiani is Chief Financial Officer (and was interim CEO July–December 2025) |
| Headquarters | London, United Kingdom |
| Financial year end | 30 June |
| Employees | Approximately 30,000 worldwide |
| Market capitalisation | ~£34.1bn (~$46bn), June 2026 |
| FY25 revenue (net sales) | $20,245m (reported, ended 30 June 2025) |
| FY25 net profit | $2,538m (basic EPS 105.9c) |
| Net debt (30 Jun 2025) | $21.9bn (3.4x net debt / adjusted EBITDA) |
2. Bull and Bear Case
Bull Case
- Unrivalled portfolio and scale: 13 billion-dollar brands across the largest categories of Total Beverage Alcohol, sales in ~180 countries, and clear leadership in tequila (Don Julio grew double digits in all regions) and in non-alcoholic spirits, where Diageo says it is more than four times the size of its nearest competitor.
- New leadership with a turnaround mandate: Sir Dave Lewis, who led the Tesco recovery, is moving fast — trimming costs, flattening the executive layer and re-pricing for affordability — which gives a credible self-help angle independent of the macro backdrop.
- Cash-focused Accelerate programme: the cost-savings target was raised to about $625m, free cash flow guidance is around $3bn for fiscal 26, and disposals (East African Breweries ~$2.3bn, the RCB business) are earmarked to cut leverage.
- Pricing power and gross-margin resilience: even in a weak year, FY25 saw slight organic gross-margin expansion, and the brand equity behind Guinness, Johnnie Walker and Crown Royal supports long-run premiumisation once the cycle turns.
- Depressed valuation: the shares trade near multi-year lows and well below their historical premium multiple, leaving room for re-rating if North America stabilises.
Bear Case
- North America still falling: the largest, highest-margin market saw organic net sales down high-single-digit in Q3 fiscal 26, and management concedes its US offer needs to become "more competitive" — the core problem is not yet fixed.
- Dividend reset: the interim dividend was cut to 20 cents and the policy reset to a 30–50% payout with a minimum 50-cent annual floor — a clear break from Diageo's long record of progressive dividends and a blow to income holders.
- Guidance cut and shrinking sales: full-year fiscal 26 organic net sales are now guided down 2–3%, with H1 fiscal 26 organic net sales already down 2.8%.
- High leverage: net debt of $21.9bn at 3.4x adjusted EBITDA limits flexibility while earnings are soft, and the dividend cut and disposals are partly in service of deleveraging.
- Structural demand questions: weaker US spirits demand, weakness in Chinese white spirits, GLP-1 weight-loss drugs and moderation trends among younger drinkers all cloud the long-term volume story.
3. Business Segments
Diageo reports by geography. The table below shows fiscal 2025 net sales by reporting segment.
| Segment | % of FY25 net sales | What it is |
|---|---|---|
| North America | 39% ($7,973m) | Largest and most profitable region — US spirits (Crown Royal, Don Julio, Casamigos, Captain Morgan) and Canada |
| Europe | 24% ($4,821m) | Guinness, Johnnie Walker, Baileys and gin across Great Britain, Ireland and continental Europe |
| Asia Pacific | 18% ($3,635m) | India (United Spirits), Greater China (incl. Chinese white spirits / baijiu), Australia, SE Asia and travel retail |
| Latin America & Caribbean | 9% ($1,847m) | Scotch, tequila and rum across Mexico, Brazil and the wider region |
| Africa | 9% ($1,834m) | Beer (Guinness, Senator, Tusker) and mainstream spirits, anchored by East African Breweries |
| Corporate & other | 1% ($135m) | Central functions and unallocated items |
4. Business Model and Moat
How it makes money. Diageo produces, markets and distributes branded alcoholic drinks — predominantly premium spirits (around 80% of net sales) plus beer (chiefly Guinness). It earns gross margins of roughly 60% by combining scale manufacturing, long-aged inventory (whisky and tequila stocks are a multi-year asset) and heavy brand investment. Marketing spend of about $3.7bn a year is the engine that sustains pricing power.
Where the moat comes from. The durable advantages are brand equity (Johnnie Walker, Guinness and Smirnoff are category-defining), aged-stock barriers to entry (a competitor cannot quickly create 12-year-old scotch or extra-aged tequila), and a global route-to-market that few rivals can match. Diageo held or grew total market share in 65% of measured-market net sales in FY25, including the US.
What is changing. Under Sir Dave Lewis the model is being re-tuned toward affordability and ready-to-drink formats — Diageo's RTD presence has slipped from around 25% to roughly 10% of the category — and toward leaner overheads via the Accelerate programme. The long-term thesis still rests on premiumisation, but the near-term playbook is cost, cash and competitiveness.
5. Financial Health
Diageo changed its presentation currency from sterling to US dollars with effect from fiscal 2025; fiscal 2024 comparatives were restated into dollars, while fiscal 2021–2023 below are shown as originally reported in sterling. All figures are from Diageo's preliminary results and half-year results press releases.
| Fiscal Year | Revenue (net sales, as reported) | YoY % | GAAP EPS | Adjusted EPS | Dividend/share | Long-term debt (YE) |
|---|---|---|---|---|---|---|
| FY21 | £12,733m | — | — | — | — | — |
| FY22 | £15,452m | +21.4% | — | — | — | — |
| FY23 | £17,113m | +10.8% | — | — | — | — |
| FY24 | $20,269m | n/m (currency change) | 173.2c | 179.6c | 103.48c | $18,616m |
| FY25 | $20,245m | (0.1)% | 105.9c | 164.2c | 103.48c | $20,820m |
FY25 reported operating profit fell 27.8% to $4,335m, driven mainly by a $1,369m exceptional impairment and restructuring charge; operating profit before exceptional items was $5,704m (down only 0.7% organically). Net cash from operating activities was $4,297m and free cash flow was $2,748m (operating cash flow less capital expenditure of $1,612m, plus disposal proceeds). Depreciation, amortisation and impairment in the cash flow statement totalled $1,718m (FY24: $493m), the jump reflecting the exceptional impairment.
The half-yearly progression below shows the most recent reported periods first; net sales and earnings per share are on the bases Diageo reports.
| Quarter / Half | Revenue (net sales) | Adjusted EPS | GAAP EPS |
|---|---|---|---|
| H1 F26 (6m to 31 Dec 2025) | $10.5bn | 95.3c | 89.7c |
| H2 F25 (6m to 30 Jun 2025) | ~$9.3bn | — | — |
| H1 F25 (6m to 31 Dec 2024) | ~$10.9bn | 97.7c | — |
| FY25 total | $20,245m | 164.2c | 105.9c |
In H1 fiscal 26 reported net sales fell 4.0% (organic down 2.8%) and the interim dividend was cut to 20 cents. Net debt at 30 June 2025 was $21.9bn, a leverage ratio of 3.4x net debt to adjusted EBITDA.
6. Valuation
Raw metrics, June 2026. Not opinions on whether the stock is cheap or expensive.
| Metric | Value |
|---|---|
| Market cap | ~£34.1bn (~$46bn) — share price 1,535.5p × ~2,222m shares |
| Trailing P/E (GAAP) | ~19.6x (market cap ~£34.1bn / FY25 profit attributable to shareholders $2,354m ≈ £1.74bn) |
| P/E (forward) | ~12.6x on a pre-exceptional basis (FY25 pre-exceptional earnings ~£2.7bn; FY26 organic operating profit guided flat to up low-single-digit) |
| P/S (TTM) | ~2.3x (market cap ~$46bn / TTM net sales ~$20.0bn) |
| EV/EBITDA (TTM) | ~10.6x (EV ~$67.9bn / adjusted EBITDA ~$6.4bn; EBITDA derived from stated 3.4x leverage on $21.9bn net debt) |
| P/FCF | ~16.7x (market cap ~$46bn / FY25 free cash flow $2.748bn; FCF = operating cash flow $4,297m − capex $1,612m + disposal proceeds) |
| Enterprise value | ~$67.9bn (market cap ~$46bn + net debt $21.9bn per 30 Jun 2025 balance sheet) |
| Market cap | ~£34.1bn (~$46bn) |
| 52-week high | ~2,214p |
| 52-week low | ~1,350p |
| Short interest (% of float) | ~0.6% (immaterial; Diageo is lightly shorted) |
| Days to cover | — immaterial (short interest below 1% of float) |
7. Growth Drivers
The nearest-term lever is the Accelerate cost programme, with the savings target raised to about $625m and roughly $300m of Accelerate benefit flagged for fiscal 26, supporting free cash flow of around $3bn. Affordability and RTDs are Sir Dave Lewis's strategic bets: rebuilding a ready-to-drink presence that has fallen to about 10% of the category, and trimming margins to allow sharper US pricing. Premium tequila and Guinness remain the structural winners — Don Julio grew double digits across every region in FY25 and Guinness delivered double-digit growth with Microdraught opening new distribution. Non-alcoholic and moderation is a fast-growing adjacency, with Diageo's non-alc portfolio up around 40% organically in FY25 and Guinness 0.0 growing double digits. Longer term, India and other emerging markets (via United Spirits and a young, premiumising consumer base) underpin the volume case, while portfolio reshaping — the EABL and RCB disposals — concentrates capital on higher-return brands and reduces leverage.
8. Peer Comparison
| Peer | Net sales / revenue (latest reported) | Key 2025 metric |
|---|---|---|
| Pernod Ricard | ~€12.1bn net sales (FY23 reference) | Closest listed rival; #2 global spirits group, also pressured in the US and China |
| Brown-Forman | ~$4.2bn net sales (FY24) | Jack Daniel's owner; direct competitor in American whiskey |
| Bacardi (private) | ~$5.3bn revenue (2023 reference) | Privately held; rum and premium spirits, nimble on pricing |
| Beam Suntory (private) | ~$5.3bn net sales (2023 reference) | Owned by Suntory; bourbon, Japanese whisky and tequila |
| Campari Group | ~€3.1bn net sales (2024 reference) | Aperitifs and premium liqueurs; high-growth bitters portfolio |
9. Insider Activity
Recent director and PDMR dealings have been disclosed under the UK Market Abuse Regulation. Non-executive director purchases included John Rishton (18 May 2026), alongside arrangements involving Sir John Manzoni (notified mid-May 2026), and routine Share Incentive Plan partnership-share purchases by executive committee members in March 2026. Diageo's Chief Executive (CEO) is Sir Dave Lewis and its Chief Financial Officer is Nik Jhangiani; both are subject to the company's shareholding requirements.
| Name | Date | Type | Shares | Price | Value | Plan Type |
|---|---|---|---|---|---|---|
| John Rishton | 18 May 2026 | Buy | 3,274 | ~£15.4 | ~£50,000 | Open-market purchase (NED) |
| Sir John Manzoni | 14 May 2026 | Buy / arrangement | Disclosed | Market | Disclosed | Company arrangement (NED) |
| Exec committee members | 10 Mar 2026 | Buy | Various | Market | Various | Share Incentive Plan (partnership/matching) |
10. Key Risks
- US demand: continued weakness in US spirits is the single biggest swing factor; a slow recovery would keep organic sales negative.
- Leverage: net debt of $21.9bn at 3.4x adjusted EBITDA constrains flexibility and was a factor behind the dividend reset and disposals.
- Dividend policy: the move to a 30–50% payout ends a long progressive-dividend record and could keep income investors away.
- Regulatory and tax: tariffs, excise duties and tighter alcohol-marketing rules across multiple jurisdictions weigh on margins and demand.
- Structural / consumer shifts: moderation among younger drinkers, the spread of GLP-1 weight-loss drugs, and weakness in Chinese white spirits all challenge long-run volumes.
- Execution: the Lewis turnaround is early-stage; senior-leadership departures during the reshuffle add transition risk.
11. Recent Developments
- 05 Aug 2025 — FY25 preliminary results. Net sales $20,245m (organic +1.7%); reported operating profit down 27.8% on a $1.4bn exceptional impairment; full-year dividend held at 103.48 cents; net debt $21.9bn.
- Dec 2025 — EABL disposal agreed. Diageo agreed to sell its East African Breweries shareholding for estimated net proceeds of ~$2.3bn, expected to complete in H2 calendar 2026 and cut leverage by ~0.25x.
- 01 Jan 2026 — Sir Dave Lewis becomes CEO. The former Tesco chief executive takes over as permanent CEO, with Nik Jhangiani returning to the CFO role after serving as interim CEO.
- Feb 2026 — H1 fiscal 26 interim results. Net sales $10.5bn (organic down 2.8%); interim dividend cut to 20 cents and payout policy reset to 30–50% with a 50-cent annual floor; FY26 guidance lowered.
- 24 Mar 2026 — RCB business sale. United Spirits announced the disposal of its RCB (popular-segment) business, part of the portfolio-reshaping drive.
- Apr 2026 — Q3 fiscal 26 trading statement. Organic net sales up 0.3%; North America still down high-single-digit; FY26 organic net sales guided down 2–3%.
- May 2026 — leadership reshuffle accelerates. Several senior executives departed as Sir Dave Lewis pivots strategy toward affordability and RTDs.
12. Key Dates
- 06 Aug 2026 — FY2026 preliminary results and Strategy Update (year ended 30 June 2026)
- 30 Jun 2026 — Fiscal 2026 financial year end
- 05 Aug 2025 — FY2025 preliminary results (most recent full-year report)
Interim (H1 fiscal 27) results are typically reported in late January / early February; the EABL disposal is expected to complete in the second half of calendar 2026. Track live prices on our Live Charts, scheduled releases on the Economic Calendar, and discuss ideas on the ChartsView Forum.
Disclaimer: This research is produced by ChartsView for educational and informational purposes only. It does not constitute financial advice or a recommendation to buy or sell any security. All information is sourced from publicly available company filings, press releases, and official data. ChartsView does not use analyst opinions or third-party ratings. Always conduct your own due diligence and consider your personal financial situation before making investment decisions. Past performance is not ind
Loading research report…
13. Thesis Verdict
The central thesis. Diageo is the world's largest premium spirits group, earning roughly 60% gross margins from iconic brands such as Johnnie Walker, Guinness and Don Julio sold across nearly 180 countries. Fiscal 2025 (to 30 June 2025) was flat-to-down — net sales of $20.2bn (organic +1.7%), reported operating profit cut 27.8% by a $1.4bn impairment, and net debt of $21.9bn at 3.4x adjusted EBITDA — and management has since cut the interim dividend and guided fiscal 2026 organic sales down 2–3%. The near-term story is new CEO Sir Dave Lewis's turnaround: cost savings via Accelerate, a pivot to affordability and ready-to-drink, and disposals (EABL, RCB) to cut leverage.
What would confirm or break it. Stabilisation in North America, delivery of the ~$625m cost programme and ~$3bn free cash flow, and successful deleveraging would confirm the recovery case. A deeper or prolonged US spirits decline, further dividend or guidance cuts, or evidence that moderation and GLP-1 trends are structurally shrinking demand would invalidate the thesis.
Watchpoints
- ConfirmsFY2026 preliminary results & Strategy Update (59 days) landing in line with or above management guidance.
- ConfirmsEvidence supporting the "Unrivalled portfolio and scale:" thesis continuing to build across subsequent filings.
- InvalidatesMaterialisation of the "US demand:" risk, or any disclosure that fundamentally alters the capital-return or growth profile stated by management.
Diagnostic grid
Generated by ChartsView research tooling. Thesis strength measures how well the evidence in this report supports the company's stated thesis — it is NOT a buy/sell rating or price target. ChartsView is not authorised by the FCA to provide regulated investment advice. Generated 8 Jun 2026.